logo
logo
Sign in

Global Transdermal Patch Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2021-2027

avatar
vivek bajaj
Global Transdermal Patch Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2021-2027

Transdermal Patch is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream.Transdermal Patches include fentanyl transdermal patch, nicotine transdermal patch, buprenorphine transdermal patch, clonidine transdermal patch, oxybutynin transdermal patch, estradiol transdermal patch, nitroglycerin transdermal patch and many others.

Transdermal Patches are mainly classified into the following types: Methyl Salicylate-based Patches, Rivastigmine Patches, Fentanyl Patches, Lidocaine Patches, Diclofenac Patches, Nicotine Patches and others. Methyl Salicylate-based segment accounted for the larger part of the revenue market, with 18%, followed by Lidocaine Patches, with 15%.

Transdermal Patches can delivery drugs through Rx Channel or OTC Channel. The former took a larger market share, with its sales volume accounting for about 76% of the total.

 

Hisamitsu Pharmaceutical, Johnson & Johnson, Nitto Denko and Mylan are the Top 4 players of the global Transdermal Patch market. They took up about 42% of the global market in 2019.

 

 

Market Analysis and Insights: Global Transdermal Patch Market

In 2020, the global Transdermal Patch market size was US$ 6429 million and it is expected to reach US$ 8379.4 million by the end of 2027, with a CAGR of 3.6% during 2021-2027.

Global Transdermal Patch Scope and Market Size

Transdermal Patch market is segmented by region, by country, company, type, application and by sales channels. Players, stakeholders, and other participants in the global Transdermal Patch market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region, by country, company, type, application and by sales channels for the period 2016-2027.

 

Segment by Type, the Transdermal Patch market is segmented into

 

  • Methyl Salicylate-based Patch
  • Rivastigmine Transdermal Patch
  • Fentanyl Transdermal Patch
  • Lidocaine Patch
  • Diclofenac Patch
  • Nicotine Transdermal Patch
  • Others

 

Segment by Application, the Transdermal Patch market is segmented into

 

  • Rx Channel
  • OTC Channel

 

Regional and Country-level Analysis:

 

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • South Korea
  • India
  • Southeast Asia
  • Australia
  • Rest of Asia-Pacific
  • Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Russia
  • Nordic Countries
  • Rest of Europe
  • Latin America
  • Mexico
  • Brazil
  • Rest of Latin America
  • Middle East & Africa
  • Turkey
  • Saudi Arabia
  • UAE
  • Rest of MEA

 

Competitive Landscape and Transdermal Patch Market Share Analysis

Transdermal Patch market competitive landscape provides details and data information by companies. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2016-2021. It also offers detailed analysis supported by reliable statistics on sale and revenue by players for the period 2016-2021. Details included are company description, major business, Transdermal Patch product introduction, recent developments, Transdermal Patch sales by region, type, application and by sales channel.

 

The major companies include:

 

  • Hisamitsu Pharmaceutical
  • Johnson & Johnson
  • Novartis
  • UCB Pharma
  • Mylan
  • Teva Pharmaceutical
  • Nitto Denko
  • Gr?nenthal
  • IBSA Group
  • GSK
  • Luye Pharma Group
  • Pfizer
  • Chattem
  • Dr Reddy?s Laboratories
  • Bayer
  • Mundipharma
  • Endo International
  • Beijing Tide Pharmaceutical

     

 


Table of content

1 Study Coverage
1.1 Transdermal Patch Product Introduction
1.2 Market by Type
1.2.1 Global Transdermal Patch Market Size Growth Rate by Type
1.2.2 Methyl Salicylate-based Patch
1.2.3 Rivastigmine Transdermal Patch
1.2.4 Fentanyl Transdermal Patch
1.2.5 Lidocaine Patch
1.2.6 Diclofenac Patch
1.2.7 Nicotine Transdermal Patch
1.2.8 Others
1.3 Market by Application
1.3.1 Global Transdermal Patch Market Size Growth Rate by Application
1.3.2 Rx Channel
1.3.3 OTC Channel
1.4 Study Objectives
1.5 Years Considered

2 Executive Summary
2.1 Global Transdermal Patch Market Size Estimates and Forecasts
2.1.1 Global Transdermal Patch Revenue 2016-2027
2.1.2 Global Transdermal Patch Sales 2016-2027
2.2 Transdermal Patch Market Size by Region: 2021 Versus 2027
2.3 Transdermal Patch Sales by Region (2016-2027)
2.3.1 Global Transdermal Patch Sales by Region: 2016-2021
2.3.2 Global Transdermal Patch Sales Forecast by Region (2022-2027)
2.3.3 Global Transdermal Patch Sales Market Share by Region (2016-2027)
2.4 Transdermal Patch Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Transdermal Patch Revenue by Region: 2016-2021
2.4.2 Global Transdermal Patch Revenue Forecast by Region (2022-2027)
2.4.3 Global Transdermal Patch Revenue Market Share by Region (2016-202

CONTACT US:
276 5th Avenue, New York , NY 10001,United States
International: (+1) 646 781 7170 / +91 8087042414
Email: [email protected]

Follow Us On linkedin :- https://www.linkedin.com/company/grand-research-store/

collect
0
avatar
vivek bajaj
guide
Zupyak is the world’s largest content marketing community, with over 400 000 members and 3 million articles. Explore and get your content discovered.
Read more